The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial
Open accessAbstract
Importance: Parkinson disease is a progressive neurologic disorder. Limited evidence suggests endurance exercise modifies disease severity, particularly high-intensity exercise. Objectives: To examine the feasibility and safety of high-intensity treadmill exercise in patients with de novo Parkinson disease who are not taking medication and whether the effect on motor symptoms warrants a phase 3 trial. Design, Setting, and Participants: The Study in Parkinson Disease of Exercise (SPARX) was a phase 2, multicenter randomized clinical trial with 3 groups and masked assessors. Individuals from outpatient and community-based clinics were enrolled from May 1, 2012, through November 30, 2015, with the primary end point at 6 months. Individuals with idiopathic Parkinson disease (Hoehn and Yahr stages 1 or 2) aged 40 to 80 years within 5 years of diagnosis who were not exercising at moderate intensity greater than 3 times per week and not expected to need dopaminergic medication within 6 months participated in this study. A total of 384 volunteers were screened by telephone; 128 were randomly assigned to 1 of 3 groups (high-intensity exercise, moderate-intensity exercise, or control). Interventions: High-intensity treadmill exercise (4 days per week, 80%-85% maximum heart rate [n = 43]), moderate-intensity treadmill exercise (4 days per week, 60%-65% maximum heart rate [n = 45]), or wait-list control (n = 40) for 6 months. Main Outcomes and Measures: Feasibility measures were adherence to prescribed heart rate and exercise frequency of 3 days per week and safety. The clinical outcome was 6-month change in Unified Parkinson's Disease Rating Scale motor score. Results: A total of 128 patients were included in the study (mean [SD] age, 64 [9] years; age range, 40-80 years; 73 [57.0%] male; and 108 [84.4%] non-Hispanic white). Exercise rates were 2.8 (95% CI, 2.4-3.2) days per week at 80.2% (95% CI, 78.8%-81.7%) maximum heart rate in the high-intensity group and 3.2 (95% CI, 2.8-3.6; P = .13) days per week at 65.9% (95% CI, 64.2%-67.7%) maximum heart rate in the moderate-intensity group (P < .001). The mean change in Unified Parkinson's Disease Rating Scale motor score in the high-intensity group was 0.3 (95% CI, -1.7 to 2.3) compared with 3.2 (95% CI, 1.4 to 5.1) in the usual care group (P = .03). The high-intensity group, but not the moderate-intensity group, reached the predefined nonfutility threshold compared with the control group. Anticipated adverse musculoskeletal events were not severe. Conclusions and Relevance: High-intensity treadmill exercise may be feasible and prescribed safely for patients with Parkinson disease. An efficacy trial is warranted to determine whether high-intensity treadmill exercise produces meaningful clinical benefits in de novo Parkinson disease. Trial Registration: clinicaltrials.gov Identifier: NCT01506479.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“aerobic exercise has been extensively researched for its role in improving cognition in AD patients and motor function in PD patients.542–545”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [544]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2014) · Medical Entomology and Zoology · Cited by 9,400
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,588
Adams, J., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W. Y., Goldenthal, S. B., Biglan, K., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,190
Goetz, C. G., Poewe, W. H., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C. E., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,360
Self-citationPharmacological Treatment of Parkinson Disease
Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,510
Goetz, C. G., Fahn, S., Martínez‐Martín, P., Poewe, W. H., Sampaio, C., Stebbins, G. T., Stern, M. B., Tilley, B. C., Dodel, R. C., Dubois, B., et al. (2006) · Movement Disorders · doi:10.1002/mds.21198 · Cited by 1,443
Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313
10.1016/b978-0-323-67762-2.50051-3
(2000) · Time to knit · doi:10.1016/b978-0-323-67762-2.50051-3 · Cited by 1,158
Research works printed but not linked: 2
- Fahn S, Elton RL. UPDRS Program Members. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163, 293-304.
- Clarke CE, Patel S, Ives N, et al; PD REHAB Collaborative Group. Physiotherapy and occupational therapy vs no therapy in mild to moderate Parkinson disease. JAMA Neurol. 2016;73 (3):291-299.
Cited by
Sorted by citations
Bloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920
Diagnosis and Treatment of Parkinson Disease: A Review
Armstrong, M. J., & Okun, M. S. (2020) · JAMA · doi:10.1001/jama.2019.22360 · Cited by 2,924
Parkinson’s disease: etiopathogenesis and treatment
Jankovic, J. J., & Tan, E. K. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322338 · Cited by 1,272
Gait impairments in Parkinson’s disease
Mirelman, A., Bonato, P., Camicioli, R., Ellis, T. D., Giladi, N., Hamilton, J. L., Hass, C. J., Hausdorff, J. M., Pelosin, E., & Almeida, Q. J. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30044-4 · Cited by 821
van der Kolk, N. M., de Vries, N. M., Kessels, R. P. C., Joosten, H., Zwinderman, A. H., Post, B., & Bloem, B. R. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30285-6 · Cited by 565
Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration
Mahalakshmi, B., Maurya, N., Lee, S., & Kumar, V. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165895 · Cited by 374
Helmich, R. C., & Bloem, B. R. (2020) · Journal of Parkinson's Disease · doi:10.3233/jpd-202038 · Cited by 300
Johansson, M. E., Cameron, I. G. M., van der Kolk, N. M., de Vries, N. M., Klimars, E., Toni, I., Bloem, B. R., & Helmich, R. C. G. (2021) · Annals of Neurology · doi:10.1002/ana.26291 · Cited by 325
Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
Church, F. (2021) · Biomolecules · doi:10.3390/biom11040612 · Cited by 325
Bloem, B. R., Henderson, E. J., Dorsey, E. R., Okun, M. S., Okubadejo, N. U., Chan, P., Andrejack, J., Darweesh, S. K. L., & Munneke, M. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30064-8 · Cited by 260
Osborne, J. A., Botkin, R., Colón-Semenza, C., DeAngelis, T. R., Gallardo, O. G., Kosakowski, H., Martello, J. P., Pradhan, S. D., Rafferty, M. R., Readinger, J. L., et al. (2021) · Physical Therapy · doi:10.1093/ptj/pzab302 · Cited by 249
Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis
Ernst, M., Folkerts, A., Gollan, R., Lieker, E., Caro-Valenzuela, J., Adams, A., Cryns, N., Monsef, I., Dresen, A., Roheger, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013856.pub2 · Cited by 251
Tsukita, K., Sakamaki-Tsukita, H., & Takahashi, R. (2022) · Neurology · doi:10.1212/wnl.0000000000013218 · Cited by 218
Barriers and Motivators to Engage in Exercise for Persons with Parkinson’s Disease
Schootemeijer, S., van der Kolk, N. M., Ellis, T. D., Mirelman, A., Nieuwboer, A., Nieuwhof, F., Schwarzschild, M. A., de Vries, N. M., & Bloem, B. R. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202247 · Cited by 199
Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade
Marras, C., Canning, C. G., & Goldman, S. M. (2019) · Movement Disorders · doi:10.1002/mds.27720 · Cited by 199
Mobilizing Parkinson’s Disease: The Future of Exercise
Ellis, T. D., & Rochester, L. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181489 · Cited by 177
Fang, X., Han, D., Cheng, Q., Zhang, P., Zhao, C., Min, J., & Wang, F. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.2421 · Cited by 171
Evidence for Early and Regular Physical Therapy and Exercise in Parkinson's Disease
Ellis, T. D., Colón-Semenza, C., DeAngelis, T. R., Thomas, C. A., Saint‐Hilaire, M., Earhart, G. M., & Dibble, L. E. (2021) · Seminars in Neurology · doi:10.1055/s-0041-1725133 · Cited by 184
Ferini‐Strambi, L., & Salsone, M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10070-8 · Cited by 155
Liu, Y., Yan, T., Chu, J. M. T., Chen, Y., Dunnett, S. L., Ho, J. Y. S., Wong, G. T. C., & Chang, R. C. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0232-y · Cited by 169
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Tsukita, K., Sakamaki‐Tsukita, H., & Takahashi, R. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14989/doctor.k23810 · Cited by 151
Current Perspectives on Aerobic Exercise in People with Parkinson's Disease
Schootemeijer, S., van der Kolk, N. M., Bloem, B. R., & de Vries, N. M. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00904-8 · Cited by 165
Cannabis Therapeutics and the Future of Neurology
Russo, E. B. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00051 · Cited by 132
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease
Amara, A. W., Wood, K. H., Joop, A., Memon, R. A., Pilkington, J., Tuggle, S. C., Reams, J., Barrett, M. J., Edwards, D. A., WELTMAN, A. L., et al. (2020) · Movement Disorders · doi:10.1002/mds.28009 · Cited by 128
Ellis, T. D., Cavanaugh, J. T., DeAngelis, T. R., Hendron, K. L., Thomas, C. A., Saint‐Hilaire, M., Pencina, K. M., & Latham, N. K. (2018) · Physical Therapy · doi:10.1093/ptj/pzy131 · Cited by 118
Exercise for Parkinson's disease
Mak, K. Y., & Wong-Yu, I. S. K. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.06.001 · Cited by 116
Ayeni, E. A., Aldossary, A. M., Ayejoto, D. A., Gbadegesin, L. A., Alshehri, A. A., Alfassam, H. A., Afewerky, H. K., Almughem, F. A., Saidu, M. B., & Tawfik, E. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912495 · Cited by 116
Exercise Effects on Multiple Sclerosis Quality of Life and Clinical–Motor Symptoms
Tollár, J., Nagy, F., TÓTH, B. E., Török, K., SZITA, K., Csutorás, B., Moizs, M., & Hortobágyi, T. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002228 · Cited by 112
Tollár, J., Nagy, F., & Hortobágyi, T. (2018) · Gerontology · doi:10.1159/000493127 · Cited by 105
Exercise and Parkinson Disease: Comparing Tango, Treadmill, and Stretching
Rawson, K. S., McNeely, M. E., Duncan, R. P., Pickett, K. A., Perlmutter, J. S., & Earhart, G. M. (2018) · Neurology Report · doi:10.1097/npt.0000000000000245 · Cited by 105
Nay, K., Smiles, W. J., Kaiser, J., McAloon, L. M., Loh, K., Galić, S., Oakhill, J. S., Gundlach, A. L., & Scott, J. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084052 · Cited by 112
α-Synuclein pathology as a target in neurodegenerative diseases
Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 116
Zhen, K., Zhang, S., Tao, X., Li, G., Lv, Y., & Yu, L. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00418-4 · Cited by 112
Exercise as medicine in Parkinson’s disease
Langeskov‐Christensen, M., Franzén, E., Hvid, L. G., & Dalgas, U. (2024) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332974 · Cited by 96
The Universal Prescription for Parkinson’s Disease: Exercise
Alberts, J. L., & Rosenfeldt, A. B. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202100 · Cited by 102
Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases
Bonanni, R., Cariati, I., Tarantino, U., D’Arcangelo, G., & Tancredi, V. (2022) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk7020038 · Cited by 100
Interventions for preventing falls in Parkinson's disease
Allen, N. E., Canning, C. G., Almeida, L. R. S., Bloem, B. R., Keus, S. H. J., Löfgren, N., Nieuwboer, A., Verheyden, G., Yamato, T. P., & Sherrington, C. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011574.pub2 · Cited by 88
Parkinson’s disease and intensive exercise therapy — An updated systematic review and meta‐analysis
Gamborg, M., Hvid, L. G., Dalgas, U., & Langeskov‐Christensen, M. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13579 · Cited by 90
Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson’s disease
Zhang, X., Xu, S., Hu, Y. H., Liu, Q., Liu, C., Chai, H., Luo, Y., Jin, L., & Li, S. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00453-9 · Cited by 95
Goldman, J. G., Volpe, D., Ellis, T. D., Hirsch, M. A., Johnson, J. A., Wood, J., Vinagre‐Aragón, A., Biundo, R., Rocco, A. D., Kasman, G. S., et al. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230117 · Cited by 93
de Laat, B., Hoye, J., Stanley, G., Hespeler, M., Ligi, J., Mohan, V., Wooten, D., Zhang, X., Nguyen, T. D., Key, J., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00641-1 · Cited by 86
The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study
Feeney, M. P., Xu, Y., Surface, M., Shah, H., Vanegas‐Arroyave, N., Chan, A. K., Delaney, E., Przedborski, S., Beck, J. C., & Alcalay, R. N. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-020-00153-8 · Cited by 79
Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis
Ernst, M., Folkerts, A., Gollan, R., Lieker, E., Caro-Valenzuela, J., Adams, A., Cryns, N., Monsef, I., Dresen, A., Roheger, M., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013856.pub3 · Cited by 94
Towards Personalized Rehabilitation for Gait Impairments in Parkinson’s Disease
Nonnekes, J. H., & Nieuwboer, A. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181464 · Cited by 76
Lee, S.-B., Kim, Y.-J., Hwang, S., Son, H., Lee, S.-K., Park, K.-I., & Kim, Y.-G. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.01.011 · Cited by 60
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Cullinane, P. W., Pablo‐Fernández, E. D., König, A., Outeiro, T. F., Jaunmuktane, Z., & Warner, T. T. (2022) · Movement Disorders · doi:10.1002/mds.29298 · Cited by 78
Marino, G., Campanelli, F., Natale, G., Carluccio, M. D., Servillo, F., Ferrari, E. S., Gardoni, F., Caristo, M. E., Picconi, B., Cardinale, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh1403 · Cited by 76
Epidemiology of Parkinson’s Disease: An Update
Deliz, J. R., Tanner, C. M., & González-Latapí, P. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01339-w · Cited by 72
How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review
Langer, A., Gassner, L., Flotz, A., Hasenauer, S., Gruber, J., Wizany, L., Pokan, R., Maetzler, W., & Zach, H. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00160-3 · Cited by 71
Mak, K. Y., & Wong-Yu, I. S. K. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202503 · Cited by 73
Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases
Santiago, J. A., & Potashkin, J. A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1185671 · Cited by 75
Landers, M. R., Navalta, J. W., Murtishaw, A. S., Kinney, J. W., & Richardson, S. P. (2018) · Neurology Report · doi:10.1097/npt.0000000000000249 · Cited by 69
Exercise and gait/movement analyses in treatment and diagnosis of Parkinson’s Disease
Burtscher, J., Moraud, E. M., Malatesta, D., Millet, G. P., Bally, J. F., & Patoz, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102147 · Cited by 75
Crowley, E. K., Nolan, Y. M., & Sullivan, A. M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.11.003 · Cited by 72
Comparing self-reported and objective monitoring of physical activity in Parkinson disease
Mantri, S., Wood, S., Duda, J. E., & Morley, J. F. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.09.004 · Cited by 65
Chasing Protection in Parkinson’s Disease: Does Exercise Reduce Risk and Progression?
Crotty, G. F., & Schwarzschild, M. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00186 · Cited by 65
Martignon, C., Pedrinolla, A., Ruzzante, F., Giuriato, G., Laginestra, F. G., Bouça‐Machado, R., Ferreira, J. J., Tinazzi, M., Schena, F. F., & Venturelli, M. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01612-1 · Cited by 63
Hunt, A. P., Minett, G. M., Gibson, O. R., Kerr, G., & Stewart, I. B. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01556 · Cited by 68
Diabetes: a tipping point in neurodegenerative diseases
Santiago, J. A., Karthikeyan, M., Lackey, M., Villavicencio, D., & Potashkin, J. A. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.09.005 · Cited by 65
Yoon, S. Y., Suh, J. H., Yang, S. N., Han, K., & Kim, Y. W. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3926 · Cited by 60
Lavin, K. M., Coen, P. M., Baptista, L. C. P., Bell, M. B., Drummer, D. J., Harper, S. A., Lixandrão, M. E., McAdam, J. S., O’Bryan, S. M., Ramos, S. V., et al. (2022) · Comprehensive physiology · doi:10.1002/cphy.c200033 · Cited by 78
Lifestyle Interventions for the Prevention of Parkinson Disease
Daalen, J. M. J., Schootemeijer, S., Richard, E., Darweesh, S. K. L., & Bloem, B. R. (2022) · Neurology · doi:10.1212/wnl.0000000000200787 · Cited by 63
Treadmill walking reduces pre-frontal activation in patients with Parkinson’s disease
Thumm, P. C., Maidan, I., Brozgol, M., Shustak, S., Gazit, E., Shema-Shiratzky, S., Bernad‐Elazari, H., Beck, Y., Giladi, N., Hausdorff, J. M., et al. (2018) · Gait & Posture · doi:10.1016/j.gaitpost.2018.03.041 · Cited by 59
Okada, Y., Ohtsuka, H., Kamata, N., Yamamoto, S., Sawada, M., Nakamura, J., Okamoto, M., Narita, M., Nikaido, Y., Urakami, H., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212782 · Cited by 58
Off-time Treatment Options for Parkinson’s Disease
Fabbri, M., Barbosa, R. P., & Rascol, O. (2023) · Neurology and Therapy · doi:10.1007/s40120-022-00435-8 · Cited by 57
O’Callaghan, A., Harvey, M., Houghton, D., Gray, W. K., Weston, K. L., Oates, L. L., Romano, B., & Walker, R. W. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01353-w · Cited by 55
Boxing for Parkinson's Disease: Has Implementation Accelerated Beyond Current Evidence?
Morris, M. E., Ellis, T. D., Jazayeri, D., Heng, H. W. F., Thomson, A., Balasundaram, A. P., & Slade, S. C. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01222 · Cited by 63
Update in therapeutic strategies for Parkinson's disease
Kulisevsky, J., de Oliveira, L. M., & Fox, S. H. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000579 · Cited by 54
Mancini, M., Afshari, M., Almeida, Q. J., Huffmaster, S. L. A., Balfany, K., Camicioli, R. M., Christiansen, C. L., Dale, M. L., Dibble, L. E., Earhart, G. M., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00897-1 · Cited by 52
Self-citationHarvey, M., Weston, K. L., Gray, W. K., O’Callaghan, A., Oates, L. L., Davidson, R., & Walker, R. W. (2018) · Clinical Rehabilitation · doi:10.1177/0269215518815221 · Cited by 52
Liu, W., Tung, T., Zhang, C., & Shi, L. (2022) · Brain and Behavior · doi:10.1002/brb3.2690 · Cited by 55
Updates and advances in the treatment of Parkinson disease
Hayes, M. W., Fung, V. S. C., Kimber, T. E., & O’Sullivan, J. D. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50224 · Cited by 49
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
Guo, Z.-H., Khattak, S., Rauf, M. A., Ansari, M. A., Alomary, M. N., Razak, S., Yang, C., Wu, D., & Ji, X. (2023) · Molecules · doi:10.3390/molecules28031283 · Cited by 49
The continuum between neurodegeneration, brain plasticity, and movement: a critical appraisal
Schirinzi, T., Canevelli, M., Suppa, A., Bologna, M., & Marsili, L. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0011 · Cited by 50
Fontanesi, C., & DeSouza, J. F. X. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.600440 · Cited by 48
Exercise for people with Parkinson’s: a practical approach
Ramaswamy, B., Jones, J., & Carroll, C. (2018) · Practical Neurology · doi:10.1136/practneurol-2018-001930 · Cited by 52
Update: Protective and risk factors for Parkinson disease
Grotewold, N., & Albin, R. L. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107026 · Cited by 53
Capato, T., de Vries, N. M., IntHout, J., Barbosa, E. R., Nonnekes, J. H., & Bloem, B. R. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191752 · Cited by 44
Physiotherapy management of Parkinson's disease
Pang, M. Y. C. (2021) · Journal of physiotherapy · doi:10.1016/j.jphys.2021.06.004 · Cited by 45
Patterson, C. G., Joslin, E., Gil, A. B., Spigle, W. A., Nemet, T., Chahine, L. M., Christiansen, C. L., Melanson, E., Kohrt, W. M., Mancini, M., et al. (2022) · Trials · doi:10.1186/s13063-022-06703-0 · Cited by 44
Self-citationManagement of freezing of gait — mechanism-based practical recommendations
Tosserams, A., Fasano, A. A., Gilat, M., Factor, S. A., Giladi, N., Lewis, S. J. G., Moreau, C., Bloem, B. R., Nieuwboer, A., & Nonnekes, J. H. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01079-6 · Cited by 43
Treatment options for postural instability and gait difficulties in Parkinson’s disease
Müller, M. L. T. M., Marušič, U., Boas, M. V. E., Weiß, D., & Bohnen, N. I. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1656067 · Cited by 48
Bhidayasiri, R., Sringean, J., Phumphid, S., Anan, C., Thanawattano, C., Deoisres, S., Panyakaew, P., Phokaewvarangkul, O., Maytharakcheep, S., Buranasrikul, V., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1386608 · Cited by 49
Gaßner, H., Steib, S., Klamroth, S., Pasluosta, C. F., Adler, W., Eskofier, B. M., Pfeifer, K., Winkler, J., & Klucken, J. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-181534 · Cited by 42
Li, J. A., Loevaas, M. B., Guan, C., Goh, L., Allen, N. E., Mak, K. Y., Lv, J., & Paul, S. S. (2023) · Neurorehabilitation and neural repair · doi:10.1177/15459683231172752 · Cited by 46
Ridgel, A. L., & Ault, D. L. (2019) · Parkinson s Disease · doi:10.1155/2019/4076862 · Cited by 40
Mobility improves after high intensity aerobic exercise in individuals with Parkinson's disease
Koop, M. M., Rosenfeldt, A. B., & Alberts, J. L. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.02.031 · Cited by 39
NEAT1 Decreasing Suppresses Parkinson’s Disease Progression via Acting as miR-1301-3p Sponge
Sun, Q., Zhang, Y., Wang, S., Yang, F., Cai, H., Xing, Y., Chen, Z., & Chen, J. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01660-2 · Cited by 39
de Oliveira, M. P. B., Lobato, D. F. M., Smaili, S. M., Carvalho, C., & Borges, J. B. C. (2021) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2021.104422 · Cited by 38
A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease
Norwitz, N. G., Dearlove, D., Lü, M., Clarke, K., Dawes, H., & Hu, M. T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.584130 · Cited by 43
de Almeida, F. O., Santana, V. P., Corcos, D. M., Ugrinowitsch, C., & Silva‐Batista, C. (2022) · Sports Medicine · doi:10.1007/s40279-022-01650-x · Cited by 38
Self-citationNew horizons in Parkinson’s disease in older populations
Chhetri, J. K., Mei, S., Wang, C., & Chan, P. (2023) · Age and Ageing · doi:10.1093/ageing/afad186 · Cited by 37
Neurodegeneration: Diagnosis, Prevention, and Therapy
Poddar, M. K., Chakraborty, A., & Banerjee, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94950 · Cited by 40
Advances in dementia with Lewy bodies
Armstrong, M. J. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211057666 · Cited by 37
Saba, R. A., Maia, D. P., Cardoso, F. E. C., Borges, V., Andrade, L. A. F., Ferraz, H. B., Barbosa, E. R., Rieder, C. R. D. M., da Silva, D. J., Chien, H. F., et al. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2021-0219 · Cited by 36
The Comprehensive Management of Cerebellar Ataxia in Adults
Stephen, C. D., Brizzi, K. T., Bouffard, M. A., Gomery, P., Sullivan, S. L., Mello, J., MacLean, J., & Schmahmann, J. D. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0549-2 · Cited by 35
Parkinson’s disease patients benefit from bicycling - a systematic review and meta-analysis
Tiihonen, M., Westner, B. U., Butz, M., & Dalal, S. S. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00222-6 · Cited by 35
Morella, I., Negro, M., Dossena, M., Brambilla, R., & D’Antona, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109718 · Cited by 36
Ceci, C., Lacal, P. M., Barbaccia, M. L., Mercuri, N. B., Graziani, G., & Ledonne, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107101 · Cited by 36
Metadata
- Authors
- Schenkman, M., Moore, C. G., Kohrt, W. M., Hall, D. A., Delitto, A., Comella, C. L., Josbeno, D. A., Christiansen, C. L., Berman, B. D., Kluger, B. M., Melanson, E. L., Jain, S., Robichaud, J. A., Poon, C., & Corcos, D. M.
- Affiliations
- University of Colorado Anschutz (US)
- University of Pittsburgh (US)
- VA Eastern Colorado Health Care System (US)
- Rush University Medical Center (US)
- University of Illinois Hospital & Health Sciences System (US)
- Northwestern University (US)
- Corresponding author
- Schenkman, Margaret
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2018-02-01
- Volume
- 75
- Issue
- 2
- Pages
- 219
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC5838616
- OpenAlex
- W2773186181
- Cited by
- 515
- References
- 45
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 82 · 2023: 71 · 2022: 66 · 2021: 70 · 2020: 38 · 2019: 33 · 2018: 24
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Parkinson's Disease Foundation
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK048520)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Balance, Gait, and Falls Prevention
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- Parkinson's disease, high-intensity exercise, treadmill exercise, motor symptoms, exercise adherence, exercise safety, moderate-intensity exercise, early-stage Parkinson's disease
- MeSH terms
- High-Intensity Interval Training, Adult, Aged, Aged, 80 and over, Exercise Test, Exercise Therapy, Female, Humans, Longitudinal Studies, Male, Middle Aged, Parkinson Disease, Retrospective Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review